Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.34 | 0.04 |
mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.35 | 0.04 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.04 |